US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Marizyme, Inc.

0.0000

0.0000

Volume:- -

Turnover:- -

Market Cap:131.79

PE:0.00

High:0.0000

Open:0.0000

Low:0.0000

Close:0.0000

52wk High:0.1195

52wk Low:0.0000

Shares:131.79M

Float Shares:61.01M

Volume Ratio:0.00

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1349

EPS(LYR):-1.4370

ROE:-3137.71%

ROA:-26.57%

PB:-0.00

PE(LYR):NaN

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Marizyme, Inc.

Exchange:

EXPERT

Establishment Date:

2007

Employees:

13

Office Location:

555 Heritage Drive,Suite 205,Jupiter,Florida,United States

Website:

http://www.marizyme.com

Zip Code:

33458

Phone:

Fax:

- -

Introduction:

Marizyme, Inc., a multi-technology biomedical company, develops and commercializes medical technologies to enhances patients health. It's product portfolio includes DuraGraft, a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure; MATLOC, a point-of-care, lab-on-chip digital screening and diagnostic device platform, developed for quantitative chronic kidney disease assessment; and Krillase, a protein enzyme that provides a therapeutics opportunity for wound healing, thrombosis, and pet health. The company also engages in the development of MAR-FG-001, a fat grafting technology for the use during fat grafting procedures. Marizyme, Inc. was formerly known as GBS Enterprises Incorporated and changed its name to Marizyme, Inc. in March 2018. The company was incorporated in 2007 and is based in Jupiter, Florida.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MRZM/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MRZM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRZM\",,,,,undefined,":{"symbol":"MRZM","market":"US","secType":"STK","nameCN":"Marizyme, Inc.","latestPrice":0.000001,"timestamp":1771621200000,"preClose":0.000001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":61006967,"shares":131793088,"eps":-0.134879,"marketStatus":"Market Closed","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":0.000001,"high":0.000001,"low":0.000001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.134879,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.000001,"volumeRatio":0.003847601548058059},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRZM\",,,,,undefined,":{"symbol":"MRZM","floatShares":61006967,"roa":"-26.57%","roe":"-3137.71%","lyrEps":-1.437042,"volumeRatio":0.003847601548058059,"shares":131793088,"dividePrice":0,"high":0.000001,"amplitude":0,"preClose":0.000001,"low":0.000001,"week52Low":0.000001,"pbRate":"-0.00","psRate":"0.00","week52High":0.1195,"institutionHeld":0,"latestPrice":0.000001,"eps":-0.134879,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.134879,"open":0.000001,"prevYearClose":0.000001,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRZM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-14","symbol":"MRZM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-28","symbol":"MRZM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1716868800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-13","symbol":"MRZM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-14","symbol":"MRZM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-18","symbol":"MRZM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1692331200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRZM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRZM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":38038239,"yearFounded":2007,"employeeNum":13,"address":"555 Heritage Drive,Suite 205,Jupiter,Florida,United States","zipCode":"33458","officePhone":"561 935 9955"},"stockCompanyDetail":{"websiteUrl":"http://www.marizyme.com","description":"Marizyme, Inc., a multi-technology biomedical company, develops and commercializes medical technologies to enhances patients health. It's product portfolio includes DuraGraft, a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure; MATLOC, a point-of-care, lab-on-chip digital screening and diagnostic device platform, developed for quantitative chronic kidney disease assessment; and Krillase, a protein enzyme that provides a therapeutics opportunity for wound healing, thrombosis, and pet health. The company also engages in the development of MAR-FG-001, a fat grafting technology for the use during fat grafting procedures. Marizyme, Inc. was formerly known as GBS Enterprises Incorporated and changed its name to Marizyme, Inc. in March 2018. The company was incorporated in 2007 and is based in Jupiter, Florida.","exchange":"EXPERT","name":"Marizyme, Inc.","nameEN":"Marizyme, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MRZM\",market:\"US\",,,undefined,":null}}